Hepion Pharmaceuticals interim CEO Gary Stetz buys $100,000 in stock — See source for full details.
$HEPA
Price history, market instrument context, member research, and related headlines in one place.
HEPA key statistics
OTC Markets OTCQBUSD
52-week range
$0.03488%$0.155
Latest session $0.12–$0.155Hepion Pharmaceuticals, Inc. (HEPA) is a stock instrument quoted on OTC Markets OTCQB in USD. The most recently published price is $0.14, up $0.01 (3.70%) from the previous close of $0.135. It has traded between $0.12 and $0.155 in the latest session. Over the past year it has ranged from $0.034 to $0.155, leaving it in the upper quarter of its 52-week range (88%). Reported volume for the session was 35.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
Hepion Pharmaceuticals director Stetz buys $25,000 in common stock — See source for full details.
Hepion Pharmaceuticals director Michael Purcell buys $100,000 in stock — See source for full details.
Hepion COO Sireesh Appajosyula buys $100,000 in common stock — See source for full details.
Hepion Pharmaceuticals executive chairman LoPriore buys $500,000 in stock — See source for full details.
Loading $HEPA research…